191 related articles for article (PubMed ID: 35577353)
21. Tanshinone IIA improves diabetes-induced renal fibrosis by regulating the miR-34-5p/Notch1 axis.
Zhang L; Yang F
Food Sci Nutr; 2022 Nov; 10(11):4019-4040. PubMed ID: 36348805
[TBL] [Abstract][Full Text] [Related]
22. Silencing of KCNQ1OT1 Decreases Oxidative Stress and Pyroptosis of Renal Tubular Epithelial Cells.
Zhu B; Cheng X; Jiang Y; Cheng M; Chen L; Bao J; Tang X
Diabetes Metab Syndr Obes; 2020; 13():365-375. PubMed ID: 32104033
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy.
Kim SK; Jung KH; Lee BC
Biol Pharm Bull; 2009 Feb; 32(2):220-4. PubMed ID: 19182379
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization
Song Z; Feng J; Zhang Q; Deng S; Yu D; Zhang Y; Li T
Front Pharmacol; 2021; 12():641848. PubMed ID: 33953677
[TBL] [Abstract][Full Text] [Related]
25. Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis.
Cao L; Huang B; Fu X; Yang J; Lin Y; Lin F
Mol Med Rep; 2017 Jun; 15(6):4247-4252. PubMed ID: 28440499
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice.
Zhang J; Cai Z; Yang M; Tong L; Zhang Y
Pharm Biol; 2020 Dec; 58(1):219-224. PubMed ID: 32202179
[No Abstract] [Full Text] [Related]
27. The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression.
Chang CC; Chu CF; Wang CN; Wu HT; Bi KW; Pang JH; Huang ST
Phytomedicine; 2014 Feb; 21(3):207-16. PubMed ID: 24157079
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
29.
Dou JY; Zhang M; Cen H; Chen YQ; Wu YF; Lu F; Zhou J; Liu XS; Gu YY
Front Pharmacol; 2022; 13():860383. PubMed ID: 35401224
[No Abstract] [Full Text] [Related]
30. Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis.
Xu S; He L; Ding K; Zhang L; Xu X; Wang S; Qian X
Drug Des Devel Ther; 2020; 14():5773-5782. PubMed ID: 33408464
[TBL] [Abstract][Full Text] [Related]
31. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy.
Wang J; Zhao SM
Life Sci; 2021 Jan; 264():118728. PubMed ID: 33160992
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
33. DNA Methylome and Transcriptome Alterations in High Glucose-Induced Diabetic Nephropathy Cellular Model and Identification of Novel Targets for Treatment by Tanshinone IIA.
Li W; Sargsyan D; Wu R; Li S; Wang L; Cheng D; Kong AN
Chem Res Toxicol; 2019 Oct; 32(10):1977-1988. PubMed ID: 31525975
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA Attenuates Contrast-Induced Nephropathy via Nrf2 Activation in Rats.
Liang R; Zhao Q; Jian G; Cheng D; Wang N; Zhang G; Wang F
Cell Physiol Biochem; 2018; 46(6):2616-2623. PubMed ID: 29763899
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA Ameliorates Inflammation Response in Osteoarthritis via Inhibition of miR-155/FOXO3 Axis.
Zhou B; Li LH; Tan LM; Luo WB; Xiong H; Lu XL; Liu D; Li WY; Guo YX; Tang Z; Zhu LG
Pharmacology; 2021; 106(1-2):20-28. PubMed ID: 33395681
[TBL] [Abstract][Full Text] [Related]
36. Lipophilic Extract and Tanshinone IIA Derived from
Zhang XW; Zhou M; An L; Zhang P; Li P; Chen J
Am J Chin Med; 2020; 48(6):1455-1473. PubMed ID: 32933312
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic effect of tanshinone IIA on Propionibacterium acnes-induced inflammation in vitro.
Li Y; Zhou Y
Dermatol Ther; 2018 Nov; 31(6):e12716. PubMed ID: 30246913
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation.
Jia S; Ma WD; Zhang CY; Zhang Y; Yao ZH; Quan XH; Guo X; Wang CX
Arch Biochem Biophys; 2019 Nov; 677():108154. PubMed ID: 31672498
[TBL] [Abstract][Full Text] [Related]
39. [Effects of tanshinone IIA on Wnt/beta-catenin signaling pathway of high glucose induced renal tubular epithelial cell transdifferentiation].
Huang BY; Cao LY; Fu XG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jul; 32(7):965-9. PubMed ID: 23019958
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy.
Xu J; Wang Q; Song YF; Xu XH; Zhu H; Chen PD; Ren YP
World J Diabetes; 2022 Apr; 13(4):358-375. PubMed ID: 35582664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
